{"id":63160,"date":"2026-04-14T23:37:02","date_gmt":"2026-04-14T15:37:02","guid":{"rendered":"https:\/\/flcube.com\/?p=63160"},"modified":"2026-04-14T23:37:03","modified_gmt":"2026-04-14T15:37:03","slug":"thermo-fishers-ppd-secures-270m-patient-healthverity-dataset-for-ai-driven-clinical-trial-optimization","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=63160","title":{"rendered":"Thermo Fisher&#8217;s PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization"},"content":{"rendered":"\n<p><strong>Thermo Fisher Scientific<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/TMO:NYSE\">NYSE: TMO<\/a>) announced a strategic <strong>data collaboration<\/strong> with <strong>HealthVerity<\/strong>, the leading <strong>real-world data (RWD) marketplace<\/strong>, to enhance <strong>data-driven clinical development<\/strong> and <strong>evidence generation<\/strong> for biopharmaceutical sponsors. Through the agreement, Thermo Fisher&#8217;s <strong>PPD clinical research business<\/strong> gains <strong>enterprise-level access<\/strong> to HealthVerity&#8217;s <strong>TaXOnomy claims dataset<\/strong>, representing more than <strong>270 million de-identified patient lives<\/strong> across the US healthcare system.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-partnership-framework\">Partnership Framework<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Data Provider<\/strong><\/td><td>HealthVerity \u2013 leading RWD marketplace<\/td><\/tr><tr><td><strong>Enterprise User<\/strong><\/td><td>Thermo Fisher Scientific&#8217;s PPD clinical research business<\/td><\/tr><tr><td><strong>Primary Dataset<\/strong><\/td><td>TaXOnomy claims dataset<\/td><\/tr><tr><td><strong>Patient Coverage<\/strong><\/td><td>270+ million de-identified patient lives<\/td><\/tr><tr><td><strong>Geographic Scope<\/strong><\/td><td>US healthcare system<\/td><\/tr><tr><td><strong>Additional Access<\/strong><\/td><td>Marketplace of 70+ curated data sources<\/td><\/tr><tr><td><strong>Data Types<\/strong><\/td><td>Claims, electronic medical records, laboratory results, specialty datasets<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-data-capabilities-amp-applications\">Data Capabilities &amp; Applications<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-core-insights-generation\">Core Insights Generation<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Disease Prevalence:<\/strong> Comprehensive epidemiological data across therapeutic areas<\/li>\n\n\n\n<li><strong>Treatment Patterns:<\/strong> Real-world medication utilization and sequencing trends<\/li>\n\n\n\n<li><strong>Provider Activity:<\/strong> Healthcare professional prescribing and referral patterns<\/li>\n\n\n\n<li><strong>Longitudinal Tracking:<\/strong> Multi-year patient journey data for outcome analysis<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-clinical-research-applications\">Clinical Research Applications<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Trial Feasibility:<\/strong> Enhanced site identification and patient recruitment projections<\/li>\n\n\n\n<li><strong>Protocol Optimization:<\/strong> Evidence-based inclusion\/exclusion criteria refinement<\/li>\n\n\n\n<li><strong>Recruitment Strategy:<\/strong> Targeted patient identification and outreach optimization<\/li>\n\n\n\n<li><strong>Real-World Evidence:<\/strong> Regulatory-grade evidence generation for regulatory submissions<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-integration-benefits\">Strategic Integration Benefits<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-enhanced-service-offerings\">Enhanced Service Offerings<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI-Driven Analytics:<\/strong> Integration with PPD&#8217;s existing artificial intelligence platforms<\/li>\n\n\n\n<li><strong>Precision Site Selection:<\/strong> Data-informed investigator site identification with higher enrollment potential<\/li>\n\n\n\n<li><strong>Accelerated Timelines:<\/strong> Reduced startup times through pre-validated site and patient availability data<\/li>\n\n\n\n<li><strong>Risk Mitigation:<\/strong> Improved trial design based on real-world treatment patterns and outcomes<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-data-ecosystem-expansion\">Data Ecosystem Expansion<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Multi-Source Integration:<\/strong> Seamless linkage between claims, EMR, lab, and specialty data<\/li>\n\n\n\n<li><strong>Curated Marketplace:<\/strong> Access to 70+ specialized datasets for comprehensive evidence generation<\/li>\n\n\n\n<li><strong>Longitudinal Depth:<\/strong> Extended patient follow-up periods enabling robust outcome assessment<\/li>\n\n\n\n<li><strong>Regulatory Compliance:<\/strong> HIPAA-compliant de-identification maintaining data utility while ensuring privacy<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-implications\">Market Implications<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-competitive-advantage\">Competitive Advantage<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Scale Leadership:<\/strong> 270M-patient dataset represents one of industry&#8217;s largest RWD assets<\/li>\n\n\n\n<li><strong>End-to-End Solution:<\/strong> Combines Thermo Fisher&#8217;s clinical operations expertise with HealthVerity&#8217;s data depth<\/li>\n\n\n\n<li><strong>Sponsor Value Proposition:<\/strong> Comprehensive evidence generation from protocol design through regulatory approval<\/li>\n\n\n\n<li><strong>Technology Integration:<\/strong> Leverages existing AI\/ML infrastructure for advanced analytics<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-industry-trends-alignment\">Industry Trends Alignment<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>RWE Adoption:<\/strong> Supports growing regulatory acceptance of real-world evidence in drug development<\/li>\n\n\n\n<li><strong>Digital Transformation:<\/strong> Accelerates clinical research digitization and data-driven decision making<\/li>\n\n\n\n<li><strong>Patient-Centric Design:<\/strong> Enables more representative trial populations through real-world insights<\/li>\n\n\n\n<li><strong>Operational Efficiency:<\/strong> Addresses industry-wide challenges in patient recruitment and site activation<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-terms\">Financial Terms<\/h2>\n\n\n\n<p>Specific financial terms of the collaboration were not disclosed. Enterprise-level data partnerships of this scale typically involve multi-year commitments with volume-based pricing structures and performance incentives.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding strategic partnerships, service enhancements, and market opportunities. Actual results may differ due to risks including implementation challenges, competitive dynamics, regulatory changes, and market adoption rates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thermo Fisher Scientific (NYSE: TMO) announced a strategic data collaboration with HealthVerity, the leading real-world&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4690,1261,523],"class_list":["post-63160","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-healthverity","tag-nyse-tmo","tag-thermo-fisher-scientific"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Thermo Fisher&#039;s PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Thermo Fisher Scientific (NYSE: TMO) announced a strategic data collaboration with HealthVerity, the leading real-world data (RWD) marketplace, to enhance data-driven clinical development and evidence generation for biopharmaceutical sponsors. Through the agreement, Thermo Fisher&#039;s PPD clinical research business gains enterprise-level access to HealthVerity&#039;s TaXOnomy claims dataset, representing more than 270 million de-identified patient lives across the US healthcare system.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=63160\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thermo Fisher&#039;s PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=63160\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-14T15:37:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-14T15:37:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63160#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63160\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Thermo Fisher&#8217;s PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization\",\"datePublished\":\"2026-04-14T15:37:02+00:00\",\"dateModified\":\"2026-04-14T15:37:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63160\"},\"wordCount\":460,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"HealthVerity\",\"NYSE: TMO\",\"Thermo Fisher Scientific\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63160#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63160\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=63160\",\"name\":\"Thermo Fisher's PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-04-14T15:37:02+00:00\",\"dateModified\":\"2026-04-14T15:37:03+00:00\",\"description\":\"Thermo Fisher Scientific (NYSE: TMO) announced a strategic data collaboration with HealthVerity, the leading real-world data (RWD) marketplace, to enhance data-driven clinical development and evidence generation for biopharmaceutical sponsors. Through the agreement, Thermo Fisher's PPD clinical research business gains enterprise-level access to HealthVerity's TaXOnomy claims dataset, representing more than 270 million de-identified patient lives across the US healthcare system.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63160#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63160\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63160#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thermo Fisher&#8217;s PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Thermo Fisher's PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization - Insight, China&#039;s Pharmaceutical Industry","description":"Thermo Fisher Scientific (NYSE: TMO) announced a strategic data collaboration with HealthVerity, the leading real-world data (RWD) marketplace, to enhance data-driven clinical development and evidence generation for biopharmaceutical sponsors. Through the agreement, Thermo Fisher's PPD clinical research business gains enterprise-level access to HealthVerity's TaXOnomy claims dataset, representing more than 270 million de-identified patient lives across the US healthcare system.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=63160","og_locale":"en_US","og_type":"article","og_title":"Thermo Fisher's PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=63160","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-14T15:37:02+00:00","article_modified_time":"2026-04-14T15:37:03+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=63160#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=63160"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Thermo Fisher&#8217;s PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization","datePublished":"2026-04-14T15:37:02+00:00","dateModified":"2026-04-14T15:37:03+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=63160"},"wordCount":460,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["HealthVerity","NYSE: TMO","Thermo Fisher Scientific"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=63160#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=63160","url":"https:\/\/flcube.com\/?p=63160","name":"Thermo Fisher's PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-04-14T15:37:02+00:00","dateModified":"2026-04-14T15:37:03+00:00","description":"Thermo Fisher Scientific (NYSE: TMO) announced a strategic data collaboration with HealthVerity, the leading real-world data (RWD) marketplace, to enhance data-driven clinical development and evidence generation for biopharmaceutical sponsors. Through the agreement, Thermo Fisher's PPD clinical research business gains enterprise-level access to HealthVerity's TaXOnomy claims dataset, representing more than 270 million de-identified patient lives across the US healthcare system.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=63160#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=63160"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=63160#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Thermo Fisher&#8217;s PPD Secures 270M-Patient HealthVerity Dataset for AI-Driven Clinical Trial Optimization"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=63160"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63160\/revisions"}],"predecessor-version":[{"id":63161,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63160\/revisions\/63161"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=63160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=63160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=63160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}